این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 17 مهر 1404
Nanomedicine Journal
، جلد ۱۲، شماره ۲، صفحات ۱۸۱-۲۰۱
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Advancements in utilizing exosomes for cancer therapy through drug delivery systems: recent developments
چکیده انگلیسی مقاله
Researchers have successfully developed and validated diverse loading strategies, utilizing both endogenous and exogenous approaches, in laboratory and animal models, showcasing their effectiveness in advancing molecular biology research. Extracellular vesicles have advantages over synthetic carriers in disease management and therapeutics. However, their clinical application is hindered by challenges such as limited specificity, low production yield, storage stability, and targeting capability. Addressing these challenges and exploring exosome engineering techniques is crucial. Cell-derived exosomes can serve as carriers for therapeutic molecules, enabling targeted drug delivery. Understanding exosome formation and developing efficient engineering methods are essential for advancing clinical therapeutic strategies. Exosomes offer a unique approach to targeted drug delivery through intercellular communication. These natural liposomes carry endogenous biomolecules, ensuring biocompatibility and allowing for cargo loading. Genetic or chemical modifications can improve targeting and drug loading capabilities. Importantly, exosomes have weak interactions with serum proteins, extending the lifespan of the cargo. By combining the capabilities of artificial nanocarriers and intercellular signaling, exosomes provide new and reliable strategies for drug administration and medical interventions. This review examines diverse exosome types, preparation methodologies, cargo encapsulation, and their efficacy in delivering therapeutic agents across different diseases. It also highlights global companies involved in the development and testing of exosome-based therapies.
کلیدواژههای انگلیسی مقاله
Exosomes, Controlled drug delivery systems, Cancer, Therapeutic biomaterials, Biomarkers
نویسندگان مقاله
| MohammadHossein Karami
Department of Chemistry, Amirkabir University of Technology, Tehran, Iran
| Majid Abdouss
Department of Chemistry, Amirkabir University of Technology, Tehran, Iran
نشانی اینترنتی
https://nmj.mums.ac.ir/article_25691.html
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Review Paper
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات